As researchers from Africa to China to America race to develop vaccines and treatments to fight Ebola, health experts are grappling with the economics of a disease that until this year had been off the drug industry's radar.
The death toll from the world's worst Ebola outbreak on record reached 3,338 people out of 7,178 cases in West Africa as of September 28, the World Health Organisation (WHO) said on Wednesday.
It said the total number of new c
Austria-based Affiris AG (AG), a developer of tailor-made drugs mainly as Peptide-based vaccines, has announced that an initial therapy against the protein alpha-synuclein, a promising Parkinson’s drug target, will enter clinical testing.
Combining two types of polio vaccine, including one that is injected rather than given orally, appears to give better immunity and could speed efforts to eradicate the crippling disease, scientists said.
Fears over the spread of deadly viruses in the Middle East have spurred Bahrain's Health Ministry to up its annual order of flu vaccine to 50,000 doses.
Recent outbreaks of H1N1 swine flu and Middle East Re
A prophylactic vaccine candidate against Chikungunya fever, developed by the Austrian biotech company Themis Bioscience induces a significant neutralizing immune response and was also confirmed as safe.
These are the major interim
US biopharma company Novavax along with a team from University of Maryland have jointly developed a vaccine that appears to effectively fight the killer Mers-coronavirus in mice, said a report.
The researchers have found a novel m
A vaccine against Chikungunya fever, developed by Vienna-based biotech company Themis Bioscience, is now undergoing clinical testing for the first time.
The vaccine, which is based on a standard anti-measles vaccine, offers an opp
British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.